NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Veradermics Surges on Analyst Backing and Promising Oral Hair Loss Data in Women

90% of women reported improved hair coverage with no major safety issues.

Veradermics Surges on Analyst Backing and Promising Oral Hair Loss Data in Women
Photo by Taylor Smith on Unsplash
Already have an account? Sign in.
07/15/2026 · 10:02 AM
MANE
/ Don’t stop at just one post.

Related↓

Veradermics’ Oral Hair Loss Pill Scores Major Win in Late-Stage Trial
04/27/2026 · 9:52 AM

Veradermics’ Oral Hair Loss Pill Scores Major Win in Late-Stage Trial

Veradermics’ hair pill VDPHL01 showed strong results, growing 30+ hairs/cm in trials, safe, and may become a new baldness treatment.

/ Subscriber only
/ Read more

Feed↓

Xos Wins First U.S. Air Force Contract, Enters Defense Market
08/17/2026 · 5:18 PM

Xos Wins First U.S. Air Force Contract, Enters Defense Market

Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.

/ Subscriber only
Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline
08/17/2026 · 4:49 PM

Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline

Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.

/ Subscriber only
EyePoint Trial Failure Seen as Positive for 4D Molecular’s 4D-150
Featured/ 08/17/2026 · 3:25 PM

B. Riley Keeps Buy on 4D Molecular After EyePoint’s Phase 3 Miss

4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe